Literature DB >> 14745055

High concordance for essential tremor in monozygotic twins of old age.

D Lorenz1, H Frederiksen, H Moises, F Kopper, G Deuschl, K Christensen.   

Abstract

OBJECTIVE: To assess the relative contribution of genetic and environmental factors for the etiology of essential tremor (ET) and to explore the effect of different diagnostic criteria.
METHODS: A total of 2,448 twins of the Danish twin registry aged 70 years or more were screened for ET by an interview and an Archimedes spiral test. All twin pairs (n = 162) with a positive screening test of at least one of the twins were recontacted and 218 individuals (109 pairs) were interviewed and examined by a movement disorder specialist. The consensus criteria of the Tremor Investigation Group were applied to diagnose ET.
RESULTS: Twenty-nine twins fulfilled the criteria of definite, 7 of probable, and 56 of possible ET. The probandwise concordance rate for the broadest definition of ET was 77% for monozygotic twins (MZ) and 59% for dizygotic twins (DZ). However, in an analysis restricted to cases of probable and definite ET, the concordance rates were 93% and 29%. The heritability for the liability to ET ranged from 93% to 99% using a general population prevalence of 1.2% for white 70+-year-olds. The inclusion of probable and exclusion of possible cases in the diagnosis of ET produced the highest concordance rates.
CONCLUSION: The high concordance among MZ twins of very old age in this first population-based twin study of ET suggests that a disease phenotype consisting of definite and probable ET has a high heritability and hence is a good candidate for a phenotype to be used in linkage studies.

Entities:  

Mesh:

Year:  2004        PMID: 14745055     DOI: 10.1212/01.wnl.0000103236.26934.41

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

1.  Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor.

Authors:  Sandra Thier; Delia Lorenz; Michael Nothnagel; Caroline Poremba; Frank Papengut; Silke Appenzeller; Steffen Paschen; Frank Hofschulte; Anna-Christina Hussl; Sascha Hering; Werner Poewe; Friedrich Asmus; Thomas Gasser; Ludger Schöls; Kaare Christensen; Almut Nebel; Stefan Schreiber; Stephan Klebe; Günther Deuschl; Gregor Kuhlenbäumer
Journal:  Neurology       Date:  2012-07-03       Impact factor: 9.910

2.  Essential tremor: is it a neurodegenerative disease? No.

Authors:  Monica M Kurtis
Journal:  J Neural Transm (Vienna)       Date:  2012-08-17       Impact factor: 3.575

Review 3.  Challenges in essential tremor genetics.

Authors:  L N Clark; E D Louis
Journal:  Rev Neurol (Paris)       Date:  2015-05-21       Impact factor: 2.607

Review 4.  Essential tremor then and now: How views of the most common tremor diathesis have changed over time.

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2017-07-13       Impact factor: 4.891

Review 5.  Essential tremor.

Authors:  Lorraine N Clark; Elan D Louis
Journal:  Handb Clin Neurol       Date:  2018

Review 6.  [Essential tremor: state of the art].

Authors:  G Deuschl; D Berg
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 7.  [Genetics of tremor].

Authors:  G Kuhlenbäumer; F Hopfner
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 8.  An update on essential tremor.

Authors:  Rodger J Elble; Günther Deuschl
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 9.  What is essential tremor?

Authors:  Rodger J Elble
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

10.  Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients.

Authors:  Delia Lorenz; Stephan Klebe; Giovanni Stevanin; Sandra Thier; Almut Nebel; Josué Feingold; Henrik Frederiksen; Elodie Denis; Kaare Christensen; Stefan Schreiber; Alexis Brice; Günther Deuschl; Alexandra Dürr
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.